Efficacy and safety of rapid escalation of cabergoline in comparison to conventional regimen for macroprolactinoma: A prospective, randomized trial

@inproceedings{Rastogi2012EfficacyAS,
  title={Efficacy and safety of rapid escalation of cabergoline in comparison to conventional regimen for macroprolactinoma: A prospective, randomized trial},
  author={Ashu Rastogi and Rama Walia and Pinaki Dutta and Anil Bhansali},
  booktitle={Indian journal of endocrinology and metabolism},
  year={2012}
}
INTRODUCTION Cabergoline (CAB) is conventionally started at a dose of 0.25-0.5 mg once a week with dose escalation at 1to 3months intervals. Previously, we and others have shown that rapid escalation and high doses of CAB can lead to normalization of serum PRL as early as 8.2 weeks in 93% of the patients. We hypothesize that rapid escalation of CAB doses… CONTINUE READING